P53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes

Leukemia Research

Volumn 35, Issue 1, 2011, Pages 99-102

  Amrein, Lilian ^a   Soulières, Denis ^b   Johnston, James B ^c   Aloyz, Raquel ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Autophagy; CLL; Dasatinib; P53

Indexed keywords

DASATINIB; INITIATION FACTOR 2ALPHA; PROTEIN P53;

ARTICLE; AUTOPHAGY; CANCER RESISTANCE; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PYRIMIDINES; THIAZOLES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650177293     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.05.029     Document Type: Article

References (9)

1. Robak T. How to improve the treatment outcome in chronic lymphocytic leukemia?. Leuk Res 2009, 34:272-275.
2. Robak T., Jamroziak K., Robak P. Current and emerging treatments for chronic lymphocytic leukaemia. Drugs 2009, 69:2415-2449.
3. Song Z., Lu P., Furman R.R., et al. Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib. Clin Cancer Res 2010, 16:587-599.
4. Amrein L., Hernandez T.A., Ferrario C., et al. Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. Br J Haematol 2008, 143:698-706.
5. Amrein P.C., Attar E., Takvorian T., et al. Dasatinib has activity in relapsed/refractory chronic lymphocytic leukemia (CLL/SLL), a phase II trial. Blood 2008, 112:1084-11084.
6. Amrein L., Panasci L., Gibson S.B., Johnston J.B., Soulières D., Aloyz R. Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro. Br J Haematol 2009, 147:396-398.
7. Pitini V., Arrigo C., Altavilla G. Dasatinib induces a response in chronic lymphocytic leukemia. Blood 2009, 113:498.
8. Tasdemir E., Maiuri M.C., Orhon I., et al. A dual role of p53 in the control of autophagy. Autophagy 2008, 4:810-814.
9. Bellodi C., Lidonnici M.R., Hamilton A., et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 2009, 119:1109-1123.